Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A Print this issue
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF November 20, 2015 | Archived Issues

P & T Approvals, FDA Statement About Plavix

Pharmacy Focus

See highlights of the October meeting of the Pharmacy and Therapeutics Committee. Also, the U.S. Food and Drug Administration says that long-term use of Plavix does not change the risk of death for patients with heart disease.

» Read more


Meetings and Events


Grand Rounds

Click here to view upcoming grand rounds.


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - November 2015 (PDF)  


Milestones

Viorica Ionut, MD, PhD, Ali Kashani, MD, and Arnold Klein, MD, have died.

» Read more

Innovation Challenge Selects 10 Semifinalists

innovation

As a part of the first MD/RN Patient Experience Innovation Challenge, more than 250 nurses and physicians came together last week to pitch collaborative solutions to improve the patient experience at Cedars-Sinai. After listening to an array of innovative ideas, the panel of six judges selected 10 semifinalist teams.

» Read more

Antimicrobial Stewardship Alerts in CS-Link

From Chris Ng, MD, Chief of Staff

In an effort to reduce antimicrobial resistance and improve patient safety, Cedars-Sinai is launching best practice alerts in CS-Link™ for patients receiving selected antibiotics for three or more days. Increasing rates of drug-resistant infections and a limited supply of new antibiotics have placed new emphasis on promoting the safe, efficient use of antibiotics at healthcare organizations across the nation.

» Read more

Building New Solutions for Patients - in a Weekend

gewertz

Startup Competition Is Part of Cedars-Sinai Initiative to Accelerate Innovation

It was a weekend of hard work and sleepless nights that began with about 35 entrepreneurs and startup enthusiasts — most of whom had just met — brainstorming about ways to improve healthcare. It ended with applause and high fives as seven teams pitched new business models they had designed during an intense 54 hours, with the goal of making life better for patients around the world.

» Read more

Cardiac Monitoring Policy Is Updated

In order to make beds with cardiac monitors available to more patients, Cedars-Sinai has adapted the 2004 American Heart Association cardiac monitoring guidelines for use as its policy concerning the utilization of cardiac monitoring of general medical-surgical adult inpatients.

» Read more

CS-Link Tip: Haiku Schedule Enhancement

If you look at your schedule on your phone, you will have noticed a change in Haiku. This enhancement allows you to see patients scheduled not only directly with you but also with other providers and resources as long as they are part of your multiprovider schedule.

» Read more

Viorica Ionut, Research Scientist, 1968-2015

Viorica Ionut

Viorica Ionut, MD, PhD, a research scientist in the Cedars-Sinai Diabetes and Obesity Research Institute and assistant professor of Biomedical Sciences, has died. She was 47. The cause was breast cancer. An expert on the role of incretins, or gut hormones, in glucose homeostasis, Ionut was a longtime collaborator of Richard Bergman, PhD, the institute's director. She also was a graduate of Cedars-Sinai's Clinical Scholars Program.

» Read more

Open Enrollment for Individual/Family Plans Runs Through Jan. 31

From Thomas M. Priselac, President and CEO

We are about to embark on the third annual open enrollment period for individual and family health insurance plans since the Affordable Care Act was signed into law. This does not impact those of you who are covered by Cedars-Sinai-sponsored health insurance plans through Anthem Blue Cross. If you receive questions from patients — or if you have friends or family members who purchase individual and family health insurance plan on their own — you can advise them that only certain plans cover care from Cedars-Sinai.

» Read more

Study Sheds Light on 'Superbug' Treatment

A new Cedars-Sinai study sheds light on how treatment of the "superbug" known as MRSA with certain antibiotics can potentially make patients sicker. The findings, published Nov. 11 in the journal Cell Host & Microbe, could have implications for managing the bug, a virulent form of the common staph infection that can be difficult to control. The study's key authors included George Liu, MD, PhD, Sabrina Mueller, PhD, and David Underhill, PhD.

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news